Is Hexarelin from Lumera Labs HPLC verified?

Yes. Every Hexarelin lot Lumera Labs ships is HPLC-purity tested at synthesis and retested by Janoshik Analytical before release. The lot-specific Certificate of Analysis is published on the Lab Results page.

Is Hexarelin sold for human use?

No. Hexarelin is sold strictly as a laboratory reference standard for in-vitro research. It is not approved by Health Canada or the FDA for human use. Every order requires a research-use declaration.

How is Hexarelin shipped?

Hexarelin is lyophilized at synthesis, sealed under nitrogen, and shipped from Kelowna, BC at -20 C through cold-chain insulated packaging via Canada Post Xpresspost. Free shipping over $200 CAD. 24-48h transit Canada-wide.

Where can I see the COA for Hexarelin?

Each shipment includes a lot-specific Certificate of Analysis. The current lot's COA is also published at https://lumerapeptide.com/lab-results/ and can be cross-referenced by the batch number printed on each vial.

Home / Catalog / Growth Axis / Hexarelin 10 mg

4.7 · 250 researcher reviews

Growth axis · Selective GH secretagogue

Hexarelin

SKU LUM-HEX-2 · C₄₇H₅₈N₁₂O₆ · 887.04 g/mol · CAS 140703-51-1

A synthetic hexapeptide growth-hormone secretagogue and ghrelin-receptor agonist. Studied for cardiovascular and pituitary-axis pharmacology.

Purity (HPLC): ≥ 99.18%
Net peptide: 5.00 mg ± 2%
Endotoxin: < 0.5 EU/mg
Format: Lyophilized vial
Storage: −20 °C, desiccated
Shelf life: 24 months from MFG

$40CAD / 10 mg vial

In stock · Lot 26-A031

Bulk 10+: $24 / vial

Add $200 for free cold-chain shipping

HPLC + MS verified per lot
Cold-chain to your door
COA bundled with shipment
Lot retains kept 5 years

Overview

Hexarelin is a synthetic hexapeptide that activates both the GHS-R1a (ghrelin receptor) and CD36, distinguishing it from more selective ghrelin-receptor agonists. The dual mechanism is investigated for cardiovascular research alongside its primary GH-releasing activity.

Each vial is lyophilized from acetate buffer, sealed under nitrogen, and shipped cold-chain at −20 °C from our Kelowna facility.

Research applications

GHS-R1a and CD36 binding-affinity assays, pituitary GH-release potentiation studies, cardiomyocyte protection screens, and comparative ghrelin-receptor pharmacology.

Sold for laboratory research only. This material is not a drug, food, or cosmetic and is not intended for diagnostic, therapeutic, or recreational use.

Identity

Parameter	Value
Sequence	His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH₂
Molecular formula	C₄₇H₅₈N₁₂O₆
Molecular weight	887.04 g/mol
CAS number	140703-51-1
Length	6 residues

Quality

Test	Specification
HPLC purity	≥ 99.0% (lot LM-2647: 99.12%)
Mass confirmation	ESI-MS within 0.5 Da
Net peptide content	≥ 80% by AAA
Endotoxin	< 0.5 EU/mg (LAL)
Bioburden	< 10 CFU/g
Residual TFA	< 1.0%

Lot LM-2647

Manufactured 04 Mar 2026 · Released 11 Mar 2026 · Tested by Lumera QC, Kelowna BC. Retain samples held under storage spec for five years from release date.

Verification

Method	Result
RP-HPLC at 220 nm	99.12% main peak
ESI-MS (positive)	887.0 Da (theor. 887.04)
Amino acid analysis	82.1% net peptide
LAL endotoxin	< 0.05 EU/mg
Karl Fischer (water)	2.8% w/w

Reconstitution

Allow vial to reach room temperature before opening (≥ 20 minutes). Reconstitute with 1.0–2.5 mL of sterile bacteriostatic water (0.9% benzyl alcohol). Inject solvent slowly down the inner wall of the vial; do not direct stream onto the lyophilized cake.

Swirl gently for 30 seconds. Do not vortex. Allow to dissolve for 5 minutes; clarity should be complete with no visible particulates.

Storage after reconstitution

Reconstituted solution is stable for 28 days at 2–8 °C in original vial. For longer storage, aliquot into low-binding tubes and hold at −80 °C; avoid repeated freeze-thaw cycles. Discard if turbidity, color change, or particulate matter is observed.